|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Albers Jeffrey W.
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-03-15 Sale |
2019-03-19 5:25 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $86.39 | $1,727,884 | 63,080 (Direct) |
View |
| 2018-11-05 Sale |
2018-11-07 4:25 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $63.49 | $1,269,709 | 915,034 (Direct) |
View |
| 2018-08-06 Sale |
2018-08-08 4:08 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $70.59 | $1,411,897 | 935,034 (Direct) |
View |
| 2018-05-07 Sale |
2018-05-09 4:29 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $78.9 | $1,578,091 | 955,034 (Direct) |
View |
| 2018-03-02 Sale |
2018-03-06 4:55 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $92.57 | $1,851,463 | 975,034 (Direct) |
View |
| 2017-11-06 Sale |
2017-11-08 4:21 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
30,000 | $70.31 | $2,109,251 | 825,034 (Direct) |
View |
| 2017-08-07 Sale |
2017-08-09 6:18 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
30,000 | $49.62 | $1,488,637 | 18,272 (Direct) |
View |
| 2017-06-28 Sale |
2017-06-30 6:18 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $50.47 | $1,009,394 | 47,920 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-03-15 Exercise |
2019-03-19 5:25 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 63,080 (Direct) |
View |
| 2019-03-15 Exercise |
2019-03-19 5:25 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 63,080 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-05 5:24 pm |
N/A 2029-03-01 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
110,500 | $86.6 | 110,500 (Direct) |
View |
| 2019-03-01 Option Award |
2019-03-05 5:24 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
29,750 | $0 | 110,500 (Direct) |
View |
| 2018-11-19 Exercise |
2018-11-21 07:20 am |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
28,961 | $1.87 | 886,073 (Direct) |
View |
| 2018-11-19 Exercise |
2018-11-21 07:20 am |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
28,961 | $1.87 | 886,073 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 4:25 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 915,034 (Direct) |
View |
| 2018-11-05 Exercise |
2018-11-07 4:25 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 915,034 (Direct) |
View |
| 2018-08-06 Exercise |
2018-08-08 4:08 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 935,034 (Direct) |
View |
| 2018-08-06 Exercise |
2018-08-08 4:08 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 935,034 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:27 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
4,152 | $0 | 4,152 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:27 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
10,729 | $0 | 4,152 (Direct) |
View |
| 2018-05-07 Exercise |
2018-05-09 4:29 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 955,034 (Direct) |
View |
| 2018-05-07 Exercise |
2018-05-09 4:29 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 955,034 (Direct) |
View |
| 2018-03-02 Exercise |
2018-03-06 4:55 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 975,034 (Direct) |
View |
| 2018-03-02 Exercise |
2018-03-06 4:55 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
20,000 | $1.87 | 975,034 (Direct) |
View |
| 2018-02-16 Option Award |
2018-02-20 5:29 pm |
N/A 2028-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
170,000 | $81.44 | 995,034 (Direct) |
View |
| 2017-11-06 Exercise |
2017-11-08 4:21 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
24,514 | $1.87 | 825,034 (Direct) |
View |
| 2017-11-06 Exercise |
2017-11-08 4:21 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO |
24,514 | $1.87 | 825,034 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sat, 23 Mar 2019 12:14:30 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |